Evidence map›Paper›PMID 24825127›Full record

ArticleScientific reports2014

Direct induction of ramified microglia-like cells from human monocytes: dynamic microglial dysfunction in Nasu-Hakola disease.

Masahiro Ohgidani, Takahiro A Kato, Daiki Setoyama, Noriaki Sagata, Ryota Hashimoto, Kazue Shigenobu, Tetsuhiko Yoshida, Kohei Hayakawa, Norihiro Shimokawa, Daisuke Miura and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Masahiro OhgidaniDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
Takahiro A Kato1] Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University [2] Innovation Center for Medical Redox Navigation, Kyushu University.
Daiki SetoyamaInnovation Center for Medical Redox Navigation, Kyushu University.
Noriaki SagataDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
Ryota Hashimoto1] Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University [2] Department of Psychiatry, Osaka University Graduate School of Medicine.
Kazue ShigenobuDepartment of Psychiatry, Asakayama General Hospital.
Tetsuhiko YoshidaDepartment of Psychiatry, Osaka University Graduate School of Medicine.
Kohei HayakawaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
Norihiro ShimokawaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
Daisuke MiuraInnovation Center for Medical Redox Navigation, Kyushu University.
Hideo UtsumiInnovation Center for Medical Redox Navigation, Kyushu University.
Shigenobu KanbaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University.
Kyushu University · JPOsaka University · JPShowa General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia have been implicated in various neurological and psychiatric disorders in rodent and human postmortem studies. However, the dynamic actions of microglia in the living human brain have not been clarified due to a lack of studies dealing with in situ microglia. Herein, we present a novel technique for developing induced microglia-like (iMG) cells from human peripheral blood cells. An optimized cocktail of cytokines, GM-CSF and IL-34, converted human monocytes into iMG cells within 14 days. The iMG cells have microglial characterizations; expressing markers, forming a ramified morphology, and phagocytic activity with various cytokine releases. To confirm clinical utilities, we developed iMG cells from a patient of Nasu-Hakola disease (NHD), which is suggested to be directly caused by microglial dysfunction, and observed that these cells from NHD express delayed but stronger inflammatory responses compared with those from the healthy control. Altogether, the iMG-technique promises to elucidate unresolved aspects of human microglia in various brain disorders.

Indexed as

Cell DifferentiationAdaptor Proteins, Signal TransducingCytokinesFemaleHumansImmunophenotypingInflammation MediatorsLipodystrophyMembrane ProteinsMicrogliaMiddle AgedMonocytesOsteochondrodysplasiasRNA InterferenceSubacute Sclerosing PanencephalitisAdaptor Proteins, Signal TransducingCytokinesInflammation MediatorsMembrane ProteinsTYROBP protein, human

Identifiers

PMID24825127
PMCPMC4019954
OpenAlexW2112951712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.